Ideas
Rotate into neglected Korean small/mid-caps.
Market leadership is shifting from large caps toward small- and mid-cap and previously neglected Korean stocks, with news and research reports becoming more important. The speaker expects the KOSDAQ to be relatively stronger while large caps rest, and advises focusing on unloved names that are only now breaking prior highs.
Daewoo E&C nuclear breakout continues.
Daewoo E&C is a leading nuclear-linked construction name whose chart has broken above its previous high and is trading near the top of volume. After a large prior gain, the speaker still sees room for upward flow as volume is digested, with the nuclear axis remaining strong.
Buy lagging Korean nuclear stocks.
Nuclear-related names are attracting funds, especially previously neglected and legacy nuclear stocks that lagged earlier. Daewoo E&C's nuclear move is spurring interest in other nuclear stocks, and the speaker expects the laggard nuclear flow to continue.
Jeju Bank leads bank stablecoin theme.
Stablecoin regulation is moving in a bank-centered direction, and Jeju Bank is viewed as one of the most advanced banks in stablecoin-related business. Its shares are rising on volume, supported by expectations and its relationship with Shinhan.
AprilBio platform validation drives rebound.
A partner's atopic dermatitis clinical success using AprilBio's SAPA long-acting platform validated the platform and triggered a limit-up, reversing the negative sentiment caused by recent insider selling.
Avoid Samsung and SK hynix near term.
Samsung Electronics and SK hynix have become expensive and their momentum has faded. Samsung may need to break its 20-day line and fall toward the 140,000 won area, while SK hynix has broken its trend and faces mechanical selling from its exchangeable-bond overhang. The speaker says there is no need to hold them now and prefers to avoid until the overhang and correction are digested, though a Samsung dip could later be an opportunity.
KB Financial as portfolio stabilizer.
Korean financials continue to outperform, and KB Financial is recommended as a portfolio stabilizer. The speaker suggests targeting stable annual returns of 15-20% with around 20% in a name like KB Financial rather than chasing 50-100% gains.
CJ Logistics breaks out on Coupang issue.
CJ Logistics is a long-consolidated logistics name that has suddenly broken out, helped by the Coupang situation. The speaker uses it as an example of the value of waiting for neglected stocks to re-rate.
SAMG Entertainment can rise further.
SAMG Entertainment reported strong Q4 results even without a movie boost. With a new Teenieping season starting and a new movie in preparation, the speaker thinks it can rise further from current levels.
Shin Daeyang Paper benefits from delivery shift.
Shin Daeyang Paper is a neglected corrugated-paper maker benefiting from delivery demand and rising corrugated paper prices. The move is more than a holiday effect because Coupang's sales decline suggests volume is shifting to Naver and large marts.
Samwha Capacitor gains on MLCC prices.
KB Securities sees MLCC prices rising about 20% in Q1. Low-end MLCC makers such as Samwha Capacitor have been neglected due Chinese competition, and the speaker sees its pattern as similar to Jeju Semiconductor's late earnings-driven rally.
Boryung jumps on Phase 3 success.
Boryung is a recently stagnant stock that has jumped after domestic Phase 3 clinical success, fitting the pattern of stocks that spike when a fresh catalyst appears.
Hanon Systems benefits from EV HVAC.
Hanon Systems broke above its previous high, and its earnings should improve through restructuring. It is also supplying HVAC systems to an Amazon-backed autonomous-driving company. EV efficiency makes advanced HVAC more important, so the speaker thinks it is being recognized globally and may be tied to the autonomous-driving theme.
DL E&C as nuclear construction laggard.
DL E&C is a construction and nuclear laggard that has been range-bound for a long time and is now moving like Daewoo E&C. It has nuclear ties, including a partnership with a US nuclear company and domestic nuclear construction experience, so it is a name to watch.
Watch LG Energy Solution for catalyst.
LG Energy Solution's chart differs from Samsung, SK hynix, and Hyundai Motor because it has already risen and is now resting. If a battery, solid-state, or robot-related catalyst emerges, it could rebound strongly, so it is a name to monitor.
Doosan Enerbility cup-with-handle setup.
Doosan Enerbility has a cup-with-handle setup similar to William O'Neil's pattern after a long correction. It is a nuclear-linked name that has not moved like other nuclear stocks, and it is worth watching for a rebound.
Korean biotech sentiment is improving.
Biotech is relatively strong, with AprilBio's clinical success lifting sentiment. In biotech, a successful clinical result or technology transfer at one company can quickly pull up other names.
Korean retail sector is strong.
Retail and distribution are among the hottest sectors. Strong asset markets in the prior year support consumption, BGF Retail and GS Retail are rising, and regulatory pressure on Coupang is helping incumbents.
BGF Retail hits new highs.
BGF Retail reported decent earnings and is hitting a 52-week high, showing the breakout pattern among previously neglected retailers.
E-Mart has multiple positive drivers.
E-Mart has three combined positives: asset value, the Coupang crackdown paving the way for early-morning delivery, and expectations of higher consumption.
DSC Investment benefits from Furiosa AI.
Furiosa AI's MPU being adopted for national AI centers and partnering with LG is lifting related venture-capital names. DSC Investment is a representative beneficiary, and the group's strength is worth watching.
Pinkfong lockup expiry may trigger rebound.
Pinkfong Company is a newly listed stock that has been depressed. Its three-month lock-up is set to expire around February 18, and lock-up expirations in already-depressed new listings often trigger rebounds, so the speaker wants to study it.
Celltrion benefits from biosimilar policy.
Trump's drug-price pressure targets PBM middlemen and pushes them toward cheaper drugs, which favors biosimilars. Celltrion has been long depressed, is now receiving attention, is linked to US policy, and its earnings are expected to grow this year and next.
Biosimilar stocks benefit from US policy.
US drug-price pressure and PBM reform should steer demand toward cheaper biosimilars, so biosimilar-related companies should have a decent flow.
Doosan and Isu track Nvidia AI.
Doosan and Isu Petasys are tied to Nvidia AI infrastructure through CCL for PCB substrates. Doosan's unlisted business supplies CCL for Blackwell and has grown rapidly, so if Nvidia infrastructure expectations increase, both can extend higher, though they currently trade with Nvidia weakness.
Hotel Shilla rebound on hotel focus.
Hotel Shilla has been in a long correction and is below its prior high. It was boosted by China inbound expectations but is pulling back. The speaker sees potential for another rebound if duty-free losses shrink and the hotel business strengthens.
Watch NCSoft gaming transition.
NCSoft's user conference for its new game was well received because it reduced monetization, but longer term AI world models could erode game developers' moat. The speaker sees it as a platform-transition story to watch rather than a clean long.
This 3PRO TV (삼프로TV) video, published February 11, 2026,
features Jang Woo-jin
discussing KOSDAQ, Korean small/mid-cap equities, 047040.KS, KORU, 006220.KS, 397030.KQ, 005930.KS, 000660.KS, 105560.KS, 000120.KS, 419530.KQ, 006740.KS, 001820.KS, 003850.KS, 018880.KS, 375500.KS, 373220.KS, 034020.KS, XBI, Korean retail/distribution sector, 282330.KS, 139480.KS, 241520.KQ, Pinkfong Company, 068270.KS, Biosimilar stocks, 000150.KS, 007660.KS, 008770.KS, 036570.KS.
27 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Jang Woo-jin
· Tickers:
KOSDAQ,
Korean small/mid-cap equities,
047040.KS,
KORU,
006220.KS,
397030.KQ,
005930.KS,
000660.KS,
105560.KS,
000120.KS,
419530.KQ,
006740.KS,
001820.KS,
003850.KS,
018880.KS,
375500.KS,
373220.KS,
034020.KS,
XBI,
Korean retail/distribution sector,
282330.KS,
139480.KS,
241520.KQ,
Pinkfong Company,
068270.KS,
Biosimilar stocks,
000150.KS,
007660.KS,
008770.KS,
036570.KS
